Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ALS Translational Research Program

NCT06885918 is registered in ClinicalTrials.gov with ALS Therapy Development Institute as lead sponsor.

NCT NCT06885918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06885918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ALS Translational Research Program
Lead sponsor
ALS Therapy Development Institute
Phase
Observational
Overall status
Recruiting
Start date
September 12, 2014
Completion date
January 31, 2035
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

als (amyotrophic lateral sclerosis), als with frontotemporal dementia (als/ftd), amyotrophic lateral sclerosis, motor neuron disease, motor neuron disease, amyotrophic lateral sclerosis